BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19397500)

  • 1. Extremely prolonged neuromuscular blockade after rocuronium: a case report.
    Morales Martín AC; Vaquero Roncero LM; Muriel Villoria C
    Acta Anaesthesiol Scand; 2009 Aug; 53(7):957-9. PubMed ID: 19397500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
    Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
    Weekes G; Hayes N; Bowen M
    Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significantly prolonged neuromuscular blockade after a single dose of rocuronium: The importance of monitoring.
    Soares M; Esteves S
    Eur J Anaesthesiol; 2016 Sep; 33(9):693-4. PubMed ID: 27136491
    [No Abstract]   [Full Text] [Related]  

  • 6. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.
    Kocabas S; Yedicocuklu D; Askar FZ
    Eur J Anaesthesiol; 2008 Nov; 25(11):940-6. PubMed ID: 18538050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolonged residual paralysis after a single intubating dose of rocuronium: an unexpected cause].
    Guerci P; Vial F; Raft J; Meistelman C; Bouaziz H
    Ann Fr Anesth Reanim; 2012; 31(7-8):632-4. PubMed ID: 22763308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged (more than ten hours) neuromuscular blockade after cardiac surgery: report of two cases.
    Olivieri L; Plourde G
    Can J Anaesth; 2005 Jan; 52(1):88-93. PubMed ID: 15625263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged neuromuscular blockade associated with rocuronium.
    Lewis KS; Santucci VN; Normoyle DL; Rothenberg DM
    Am J Health Syst Pharm; 1999 Jun; 56(11):1114-8. PubMed ID: 10385459
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-lasting potentiation of a single-dose of rocuronium by amikacin: case report.
    Gilliard V; Delvaux B; Russell K; Dubois PE
    Acta Anaesthesiol Belg; 2006; 57(2):157-9. PubMed ID: 16916186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of a rocuronium-induced neuromuscular block in patients receiving prednisolone.
    Soltész S; Mencke T; Stunz M; Diefenbach C; Ziegeler S; Molter GP
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):443-8. PubMed ID: 19317861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of subcutaneous infiltration of rocuronium: A case report.
    Timmermann TN; Mongan PD; Hoefnagel AL; Braunecker S
    J Clin Anesth; 2021 Aug; 71():110203. PubMed ID: 33609852
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative Neuromuscular Blockade Monitoring: Two Pictures of Unexpected Rocuronium Effect: A Case Report.
    Leonard PA; Todd MM
    A A Case Rep; 2017 Oct; 9(7):190-192. PubMed ID: 28542054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis incidence with rocuronium, succinylcholine, and atracurium: how risk communication can influence behavior.
    Dewachter P; Mouton-Faivre C
    Anesthesiology; 2015 Sep; 123(3):735-6. PubMed ID: 26284871
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged residual paralysis after a single intubating dose of rocuronium.
    Claudius C; Karacan H; Viby-Mogensen J
    Br J Anaesth; 2007 Oct; 99(4):514-7. PubMed ID: 17675361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High need for sugammadex for rocuronium reversal with acute renal failure and normal need in the same patient with no renal impairment.
    Valente A
    J Clin Anesth; 2020 Dec; 67():109981. PubMed ID: 32682252
    [No Abstract]   [Full Text] [Related]  

  • 20. Residual neuromuscular block in type II diabetes mellitus after rocuronium: a prospective observational study.
    Armendáriz-Buil I; Lobato-Solores F; Aguilera-Celorrio L; Morros-Díaz E; Fraile-Jiménez E; Vera-Bella J
    Eur J Anaesthesiol; 2014 Aug; 31(8):411-6. PubMed ID: 24201596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.